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Abstract Cytochrome P450 2D6 is a major drug-meta-
bolising enzyme with a wide substrate range. A single-
point mutation introduced in this enzyme induces stereo-
selective binding of R and S-propranolol whereas the wild
type has no preference. The system has previously been
studied both experimentally and computationally (de Graaf
et al. in Eur Biophys J 36:589–599, 2007a). The in silico
study reported hysteresis and significant deviations from
closure of thermodynamic cycles, probably because of lack
of sampling. Here, we focus on the effect of prolonged
simulation time and enhanced sampling methods, such as
Hamiltonian replica exchange, to reduce these problems
and to improve the precision of free energy calculations.
Finally we rationalize the results at a molecular level and
compare data with experimental findings and previously
estimated free energies.
Keywords Hamiltonian replica exchange  CYP2D6 
Stereoselectivity  Free energy calculations  Improved
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Introduction
The cytochrome P450s (CYPs) are a superfamily of heme
containing oxido-reductase enzymes; because of their wide
substrate range they are of crucial importance in the
metabolism of a variety of compounds. Cytochrome P450s
are present in all five biological kingdoms, and are
particularly important in the metabolism of drugs admin-
istered to humans. CYP2D6, the second most important
Cytochrome P450, is involved in the metabolism of more
than 15 % of commercial pharmaceuticals (Rendic 2002;
van Waterschoot et al. 2006; Pelkonen et al. 2008). In
addition to this, its genetic diversity highlights the impor-
tance of understanding metabolism by this enzyme, as well
as its inhibition (Ito et al. 2008). The function of various
active site residues in the binding and metabolic profiles of
substrates and inhibitors has been thoroughly studied
(de Graaf et al. 2007b). One of these studies (Lussenburg
et al. 2005) revealed that the F483A mutation may change
substrate specificity and regioselectivity. This particular
mutation induced stereoselectivity of propranolol (PPD)
binding, because the binding affinity of R-PPD was
reduced by a factor of 20 in the mutant whereas the affinity
of S-PPD remained similar to the affinity in the wild type
enzyme. This experimental find was followed by compu-
tational studies by de Graaf et al. (2007a) which suggested
use of four different approaches to estimate the stereose-
lectivity of CYP2D6 and its mutant F483A toward pro-
pranolol. Although some of the results in this paper were in
very good agreement with experimentally determined free
energies, the paper also reported internal inconsistencies in
the form of different free energies for forward and reverse
processes (hysteresis) and a failure to close thermodynamic
cycles, along which the free energy estimates should add
up to zero. The simulations were started from a homology
model of the enzyme, and were relatively short, suggesting
insufficient sampling of the conformational space. In
accordance with their wide substrate specificity CYPs are
known to have remarkable flexibility and malleability in
their active sites (Guengerich 2006; Oostenbrink et al.
2012). The only available X-ray structure of CYP2D6 at
the start of this work (pdb code 2F9Q) was an apo structure
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in which the active site was relatively small (Rowland et al.
2006). It was, therefore, not suitable for explaining the
metabolism of many substrates, whereas the homology
model (de Graaf et al. 2007b) or structures derived from
careful molecular dynamics (MD) simulations (Hritz et al.
2008) may be more appropriate for the task. Other exam-
ples are available in papers by Kjellander et al. (2007) and
Rydberg and Olsen (2012). Recently, holo structures of
CYP2D6 with different ligands have become available
(pdb codes 3QM4, 3TMB, 3TDA); these confirm the
dynamic behaviour of F483 observed in MD simulations
(Hritz et al. 2008). Note that the latter work also implicated
F483 as being crucial to understanding the binding of
substrates. The flexibility and malleability of the active site
are also significant challenges to accurate free energy
calculations, which depend on sufficient sampling of the
conformational space to capture all energy and entropy
contributions (Beveridge and Dicapua 1989; Kollman
1993; Chipot and Pearlman 2002).
Here we will rebuild the original thermodynamic cycles
of CYP2D6 wild type and F483A mutant enzymes with
PPD enantiomers, on the basis of the available crystallo-
graphic structure (Rowland et al. 2006). By using prolonged
simulation times and advanced sampling methods—i.e.
Hamiltonian replica exchange—we improve the precision
of the reported free energy calculations.
Methods
All molecular dynamics simulations were carried out using
the GROMOS11 package for molecular simulations (Rin-
iker et al. 2011; Schmid et al. 2012). Molecular interactions
were described according to GROMOS force field param-
eter set 45A4 (Lins and Hu¨nenberger 2005; the slightly
different 43A1 (Daura et al. 1998) set was used in the
original approach). Initial coordinates were derived from
the crystal structure of CYP2D6 (pdb 2F9Q). Note that the
N-terminal membrane anchor of 33 amino acids is missing
from this model. Propranolol was carefully modelled into
the active site by means of gradual molecular insertion, as
described elsewhere (Hritz et al. 2008). Free energy cal-
culations were performed by using thermodynamic inte-
gration (TI) (Kirkwood 1935), and Hamiltonian replica
exchange (HRE; Sugita et al. 2000; Fukunishi et al. 2002;
Woods et al. 2003). Visualisation was done by using
PyMol (Schro¨dinger 2009) molecular graphics systems
version 1.2r.2.
Simulation setup
The CYP2D6 wild type enzyme with R-propranolol in the
binding site was solvated in a rectangular box containing
17019 simple point charge (SPC) (Berendsen et al. 1981)
water molecules and 5 Na? ions. Individual CYP2D6 and
R-propranolol structures were simulated after solvation in
cubic SPC water boxes (containing 16,659 water molecules
and 6 Na? ions, and 1,812 water molecules, respectively).
The systems were equilibrated and heated from 60 to
298 K while gradually removing the positional restraints
on the solute atoms (initial force constant 2.5 9 104
kJ/mol/nm2) in five discrete simulations of 20 ps. All
simulations were performed under periodic boundary
conditions, using a 2-fs time step and the SHAKE algo-
rithm (Ryckaert et al. 1977) to constrain bond lengths and
H–O–H bond angles. The weak-coupling algorithm (Ber-
endsen et al. 1984) was used to maintain constant tem-
perature and pressure, with relaxation times of 0.1 and
0.5 ps, respectively. Overall translational and rotational
motion was removed every 1,000 steps, and for long-range
interactions the reaction field method (Tironi et al. 1995)
was used with a 1.4 nm cutoff and 61 as dielectric per-
mittivity (Heinz et al. 2001). Error estimates were calcu-
lated from block averages (Allen and Tildesley 1989).
Thermodynamic integration
TI simulations are widely accepted standard methods used
to obtain free energies for alchemical changes in equilib-
rium molecular dynamics (Kirkwood 1935; Kollman
1993). A (virtual) reaction coordinate (k) between two
physically meaningful end states is defined, and a series of
MD simulations is started from an initial state via discrete
intermediate values of k, until the other end state is
reached. At each individual point along the path, the
ensemble average of the derivative of the Hamiltonian (H)
with respect to k is determined, and the free energy dif-
ference (DG) is obtained by integrating over the derivatives









Because free energy is a state function, the free energy
difference is completely defined by the two end states and
not by the intermediates. However, obtaining the correct free
energy value requires properly converged ensemble
averages at each k. A schematic depiction of TI can be
seen in Fig. 1a. In an ideal simulation with infinite
simulation time, the free energy obtained is independent
from the end state from which the simulation is initiated, but
this might not be true in practice. Because TI simulations are
commonly started from conformations obtained at previous
k points (after some equilibration), energy barriers might
lead to very different sampling of conformational space—
depending on the starting structure—leading to different
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calculated free energies. The difference between the free
energy estimates for the forward and backward processes is
called hysteresis.
Here, two series of TI simulations were carried out for
each individual change (see the section ‘‘Simulated pro-
cesses’’, below). Preliminary TI simulations were per-
formed with 120 ps simulation time per k point. These
simulations enabled us to determine the initial hysteresis
and deviations from cycle closure. Furthermore, it was also
used to determine whether additional k points are required
to obtain a smooth free energy profile, and to generate
starting coordinates for the main TI and HRE simulations.
The preliminary TI simulations were started from the last
frame of a 1-ns classical MD simulation of the wild type
enzyme with R-PPD, or from the equilibrated structures of
either R-PPD or wild type CYP2D6. The main TI runs were
started as prolongation of the preliminary runs, however,
slight modifications were introduced (see below). Each
prolonged TI simulation was performed for 1 ns per k point
and was evaluated independently from the preliminary
simulation.
Hamiltonian replica exchange
Hamiltonian replica exchange TI methods share principles
with TI, but all MD simulations for different states (the
replicas) are started independently, and simultaneously. At
given time periods (here 4 ps), neighbouring replicas are
allowed to exchange their k values, following the Metrop-
olis criterion (Sugita et al. 2000; Woods et al. 2003). A
schematic representation of the HRE process is shown in
Fig. 1b. This approach helps the individual replicas to visit
hard-to-reach parts of the conformational space, should an
energy barrier exist in some of the states only (Woods et al.
2003; Riniker et al. 2011; Steiner et al. 2011). After the
simulations are finished, the trajectory of each replica is
sorted according to k—thus obtaining an ensemble average
at each k point—and the free energy of the process is
determined with the same integration as described above
(Eq. 1). The possibility of exchanging coordinates between
k values should improve conformational sampling at each k
point, leading to a more precise free energy profile, and
better convergence of the calculated free energy differences.
Fig. 1 Schematic
representation of the free energy
methods used here.
a Thermodynamic integration
simulations: on the left, different
colours represent the individual
MD simulations started
sequentially at different k
points; on the right the oH=ok
ensemble average and
uncertainty is shown (free
energy profile); these are used




simultaneously and are allowed
to exchange between k points to
obtain a better ensemble
average. Replica 2 started from
k point 0.166 is marked with a
thicker line to show how it visits
all intermediate states. The
boxed trajectory from different
replicas was used to calculate
the ensemble average for
k = 1.0
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All HRE simulations were performed using the same
parameters as the main TI simulations, for 1 ns over all k
values. Because of hardware limitations the F483A muta-
tions could only be performed using 12 replicas (and k
points) instead of the 16 k points of TI. The number of
k points for the PPD inversions was not changed, but the k
points were slightly shifted for the HRE simulation to
promote exchange probabilities in regions where exchange
was relatively seldom. Replica exchange starting coordi-
nates were taken from the preliminary TI simulations of the
appropriate k points.
Simulated processes
Two types of alchemical change were introduced: mutation
of phenylalanine 483 into alanine and inversion of pro-
pranolol from the R configuration to the S configuration.
For the TI calculations the reverse processes were also
performed, using the last frame of the forward process as
the starting coordinates. For replica exchange TI simula-
tions—as the directionality of the process disappears—a
single simulation per process was performed.
F483A mutations
The F483 mutation in CYP2D6 was simulated by changing
atoms of the phenyl ring into non-interacting dummy atoms
and turning the CH2 group of the beta carbon into a CH3
group, as depicted in Fig. 2. To smoothen molecular
changes, soft core potentials (Beutler et al. 1994) were used
with soft core values of 0.5 nm2 for electrostatic interac-
tions and 0.5 for the Van der Waals interactions. Mutations
of F483A are abbreviated as Mut, Mut_R, Mut_F, and
Mut_S, indicating mutation processes in the absence of
PPD, with R-PPD, with a planar PPD intermediate, or with
S-PPD bound, respectively. After the preliminary TI sim-
ulations, five additional (to the initial 11) k points were
inserted for mutations, to make the integration curve
smoother. Mutation type processes now consist of 16
simulations for TI at k points 0.0, 0.05, 0.1, 0.15, 0.2, 0.3,
0.4, 0.5, 0.6, 0.7, 0.8, 0.85, 0.9, 0.93, 0.95, and 1.0; and 12
simulations for HRE (not including 0.05, 0.15, 0.93, 0.95).
PPD inversions
As the chiral CH group is described by a single atom in the
GROMOS 45A4 united atom force field the inversion type
process involves solely the improper dihedral angle on the
chiral centre (depicted in a lighter shade in Fig. 3). The
zero improper dihedral energy angle was changed from
?35.26 (R-PPD) to -35.26 (S-PPD). The change was
introduced in two steps, first by changing the R-PPD into a
planar intermediate (called F-PPD), then changing the
intermediate state into S-PPD. The bond angles around the
chiral centre were also increased to 120 in the F-PPD
state. Because it was found in simulations of PPD in water
that the head torsion was not sampled properly, the force
constant of this covalent dihedral angle interaction was
reduced to 0 kJ/mol for the planar intermediate state of the
molecule. A representation of the PPD inversion defining
the head torsion is depicted in Fig. 3. Inversion processes
are named IRF, IFS, or Inv for conversion from R-PPD to
F-PPD, F-PPD to S-PPD, and for full inversion, respec-
tively, followed by _wt or _M if the process takes place
inside a wild type or mutant CYP2D6. Inversions were
done using 2 9 7 k points for both TI (0.0, 0.1, 0.3, 0.5,
0.7, 0.9, 1.0) and HRE (0.0, 0.16, 0.34, 0.5, 0.66, 0.83, 1.0)
simulations.
Results and discussion
De Graaf et al. described four different approaches with
different thermodynamic cycles, which were handled sep-
arately, and could directly be compared to the relative
binding free energies derived from the dissociation con-
stants of spectral titrations. Here, we also calculate these
free energies, and join the free energy differences into a
single, thermodynamic scheme in Fig. 4. This enables us to
monitor the hysteresis and deviations from cycle closure of
our simulations. Additionally, the free energies of all pro-
cesses were calculated by using an increasing amount of
simulation time to monitor the evolution of free energies,
hysteresis, and deviation from cycle closure. Finally, the
trajectories from all simulations that represent the physi-
cally meaningful end states of the different processes were
collected and analysed together, to obtain differences in the
average behaviour of the end states and to find a structural
rationalization of the hysteresis in our systems.
Fig. 2 Phenylalanine mutation process. Stick representation of
phenylalanine 483 and its change to alanine. Carbon atoms
represented in dark gray, hydrogens in light gray, oxygen in red,
nitrogen in blue, and dummy atoms in white. The side chain torsion,
v1, is depicted in orange. CB was changed from a CH2 group in F483
into a CH3 in A483
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Rebuilding the cycles
The thermodynamic scheme in Fig. 4 was gradually built along
the various simulation arrows, starting from the CYP2D6 wild
type and R-PPD state (WT ? R-PPD). The integrated
free energies of all processes, calculated from forward and
reverse TI simulations and HRE TI after 1 ns are shown in
Table 1. From these integrated free energies we calculated a
number of derived quantities in Table 2, as described below:
Inversions
The inversions are calculated on the basis of Eq. 2, where
_wt and _M may be added to the index to represent the
inversion bound to wild type or mutant CYP2D6.
DGInv ¼ DGIRF þ DGIFS ð2Þ
The value of DGInv corresponds to the free energy
difference between R-PPD to S-PPD in aqueous solution.
The inversion in water is an important inner standard,
because in an achiral environment the free energy of the
PPD inversion should be 0 kJ/mol. This criterion is met
in both methods within the uncertainty ranges. The
requirement DGInv * 0 kJ/mol was also met in the
preliminary TI calculations, but the head torsion (Fig. 3)
of PPD had a very different distribution from independent
simulations of the F-PPD state (data not shown). This
indicated insufficient sampling, for which the barrier of
this torsion was removed in F-PPD for the remaining
simulations.
Fig. 3 Propranolol inversion.
Stick representation and
topological model of inversion
of propranolol via a planar
intermediate. Carbon atoms
represented in dark gray,
hydrogens in light gray, oxygen
in red, and nitrogen in blue. The
head–tail distance is represented
by a dashed orange line, the
head torsion by a green dot-
dash line, and the chiral
improper dihedral angle by a
red dotted line
Fig. 4 Thermodynamic
scheme. End states are
connected by arrows, where WT
is wild type CYP2D6, Mut is
CYP2D6 mutant F483A,
R-PPD is R-propranolol, S-PPD
is S-propranolol, and F-PPD is
the planar intermediate. Each
arrow represents a
thermodynamic integration
simulation, which was used to
build the scheme starting from
the WT ? R-PPD state. WT and
R-PPD models were made by
removing the appropriate
molecules from the
WT ? R-PPD model
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Cycle closure
The free energy change along the main cycle should lead to
a value of 0 kJ/mol exactly, as free energy is a state
function. The different estimates of the cycle closure were
calculated as follows (Fig. 4):
DGforcycle ¼ DGforInv wt þ DGforMut S þ DGrevInv M þ DGrevMut R
ð3Þ
DGrevcycle ¼ DGforMut R þ DGforInv S þ DGrevMut S þ DGrevInv wt
ð4Þ
DGhrecycle ¼ DGhreInv wt þ DGhreMut S  DGhreInv M  DGhreMut R
ð5Þ
For the preliminary TI runs the average DGcycle
was more than 20 kJ/mol; in the prolonged TI cycle only
8 kJ/mol remains whereas for the replica exchange cycle
2.5 kJ/mol was calculated. Because the uncertainty for
cycle closures is approximately 4 kJ/mol, the cycles did not
close in the TI calculations.
Hysteresis
Hysteresis is defined as the difference between the free
energies associated with the forward and reverse simula-
tion of a process. By definition, hysteresis is not observed
for the HRE simulations. For TI simulations the hysteresis
can be calculated directly from Table 1. Taking the
uncertainties into account only 5 of the 10 processes are
free from hysteresis, after 1 ns of simulation at every k




DGfor þ DGrev  ð6Þ
DGhysteresis amounts to *50 kJ/mol, of which 74 % can
be attributed to the Mut and Mut_F processes, which are
not part of the main cycle.
Approach 1: relative binding free energy differences
The difference between R-PPD and S-PPD binding to a
CYP2D6 enzyme—calculated with a thermodynamic cycle
from the inversion of PPD in water and in the appropriate
protein—can be estimated by use of Eqs. 7 and 8.
DDGWTbind ¼ DGInv wt  DGInv ð7Þ
DDGMutbind ¼ DGInv M  DGInv ð8Þ
Because the wild type CYP2D6 shows no
stereoselectivity (de Graaf et al. 2007a) we expect a
binding free energy difference near 0 kJ/mol for the wild
type enzyme. Similarly, in the mutant S-PPD binds more
strongly, suggesting a more negative value for DDGMutbind.
However, in agreement with the previous computational
results (de Graaf et al. 2007a), our calculations show
binding is less favourable for S-PPD in the wild type
(positive DDGWTbind) and that there is almost no difference
within the mutant.
Approach 2: propranolol transfer free energy difference
The relative difference of free energies of transfer of
R-PPD and S-PPD from the CYP2D6 wild type to the
mutant can be calculated with a thermodynamic cycle from
the inversion free energies within the proteins, and is
identical with the differences of DDGbind.







DGMut 19.7 ± 2.4 -0.7 ± 3.2 8.8 ± 2.9
DGMut_R 23.1 ± 3.3 -20.6 ± 3.3 24.4 ± 2.3
DGMut_F 29.3 ± 1.6 -10.0 ± 2.6 –
DGMut_S 18.1 ± 2.2 -17.0 ± 2.5 21.2 ± 2.2
DGIRF -9.1 ± 0.3 8.9 ± 0.5 -8.9 ± 0.3
DGIFS 8.6 ± 0.5 -8.8 ± 0.5 8.6 ± 0.3
DGIRF_wt -1.1 ± 0.7 3.8 ± 0.8 -2.1 ± 0.6
DGIFS_wt 14.4 ± 1.3 -17.8 ± 1.1 9.2 ± 0.9
DGIRF_M -4.6 ± 0.7 4.7 ± 0.8 -6.5 ± 0.7
DGIFS_M 7.6 ± 0.9 -4.4 ± 0.8 8.0 ± 0.7
Free energy differences for all processes of the thermodynamic
scheme in Fig. 4 for forward (DGfor) and reverse (DGrev) TI and
Hamiltonian replica exchange (DGhre) schemes, and their statistical
uncertainty after 1 ns per k point simulation time







DGInv 0.5 ± 0.6 0.1 ± 0.7 0.3 ± 0.5
DGInv_wt 13.3 ± 1.5 14.0 ± 1.4 7.1 ± 1.1
DGInv_M 3.0 ± 1.1 -0.3 ± 1.1 1.5 ± 1.0
DDGbind
WT 13.8 ± 1.6 14.0 ± 1.5 7.5 ± 1.2
DDGbind
Mut 3.5 ± 1.2 -0.2 ± 1.3 1.8 ± 1.1
DGtransfer -10.3 ± 1.8 -14.2 ± 1.8 -5.7 ± 1.5
DDGmut
R 3.3 ± 4.0 19.9 ± 4.6 15.5 ± 3.7
DDGmut
S -1.6 ± 3.3 16.3 ± 4.0 12.3 ± 3.6
DDGexchange -5.0 ± 3.9 -3.6 ± 4.1 -3.2 ± 3.2
DGcycle 5.3 ± 4.3 10.6 ± 4.5 2.5 ± 3.6
DDGaffinity -7.6 ± 2.9 -8.9 ± 4.5 -4.4 ± 3.6
Calculated directly from Table 1. Quantities were calculated for
forward (DGfor) and reverse (DGrev) TI, and Hamiltonian replica
exchange (DGhre) schemes
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DDGtransfer ¼ DGInv M  DGInv wt ¼ DDGMutbind  DDGWTbind
ð9Þ
Approach 3: the effect of PPD on F483A mutation
The presence or absence of PPD modifies the free energy
of mutation. This effect can be calculated from the free
energy of mutation without PPD and with either R-PPD or
S-PPD.
DDGRmut ¼ DGMut R  DGMut ð10Þ
DDGSmut ¼ DGMut S  DGMut ð11Þ
Approach 4: PPD exchange between CYP2D6 forms
The relative free energy difference of exchanging R-PPD
with S-PPD in the wild type and mutant CYP2D6 can
be calculated from mutation processes with R-PPD and
S-PPD, and is identical with differences of DDGmut.
DDGexchange ¼ DGMut S  DGMut R ¼ DDGSmut  DDGRmut
ð12Þ
Although the different approaches yield different
relative free energies, DDGexchange (approach 4) and
DDGtransfer (approach 2) should be equal if the main
thermodynamic cycle closes. The original values amount to
4.9 and -7.5 kJ/mol respectively (de Graaf et al. 2007a),
and we calculated -4.3 and -12.3 kJ/mol for the TI cycles
(averaged over forward and reverse cycles), and -3.2 and
-5.7 kJ/mol for the Hamiltonian replica exchange
calculations. The obvious improvement of the relative
free energies is that both approaches now point in the same
direction, in contrast to the original two values. The value
of DDGexchange and DDGtransfer derived from experimental
values is -7.7 kJ/mol. If we average the two relative free
energies using Eq. 13, we obtain the relative affinity
difference of wild type and mutant CYP2D6.
DDGaffinity ¼ ðDDGexchange þ DDGtransferÞ=2 ð13Þ
The calculated value DDGaffinity is -8.3 and -4.5 kJ/mol
for TI and HRE calculations respectively, which suggest that
replica exchange slightly underestimates the free energies
whereas TI results in significant scatter of the values
(individual forward and reverse estimates ranging from
-3.6 to -14.2 kJ/mol).
Evolution of thermodynamics
To evaluate the effect of simulation time length on con-
vergence of the free energy differences, the summed
absolute hysteresis for the TI simulations (Eq. 6), and
DGcycle (Eqs. 3–5) and DDGaffinity (Eq. 13) for both TI and
HRE cycles were calculated after increments of 200 ps of
simulation time. The results of our calculations are shown
in Table 3. As expected, the uncertainty in the quantities
obtained decreases slightly with increased simulation time.
Surprisingly, cycle closure was already much improved in
the HRE calculations after only 200 ps (the increase at 1 ns
is still well within the uncertainty) whereas in the TI
scheme both hysteresis and DGcycle gradually decrease as
sampling improves. Interestingly, DDGtransfer for TI and
HRE simulation differ significantly, but both values decrease
over time.
The effect of simulation time on individual processes
was also investigated. In many cases, forward TI simula-
tions seemed better converged than their reverse counter-
parts, especially for the mutation type processes, where the
PHE483 side chain needs to find the proper orientation. For
the replica exchange simulations, the free energy differ-
ences are not so dependent on the simulation time, but are
somewhat higher than either of the TI simulations. In
Table 4 we show the free energy change of the mutation
process without propranolol (Mut), for which hysteresis is
largest in Table 1. The free energy estimate from the for-
ward mutation remains relatively stable, in terms of both
free energy and uncertainty (19 ± 2.3 kJ/mol); although
the reverse estimates of these both decrease gradually, the
hysteresis still remains at 19 kJ/mol after 1 ns at every k
point. Interestingly, the forward simulation was repeated
starting from the final configuration of the reverse process,
and a very similar estimate (16.9 ± 3.5 kJ/mol) as for the
first forward calculation was obtained once again. This
suggests that the hysteresis does not occur because the
reverse simulation leads to an alternative configuration, but
rather that the sampling in the two directions is insuffi-
ciently complete. The HRE simulation of this process
yields a free energy estimate between the forward and
reverse simulations, which might suggest mixing of mul-
tiple conformational states appearing at different k points.
Figure 5 shows the free energy profiles for these processes,
where the data for the reverse simulation are inverted for
Table 3 Thermodynamic changes with increased simulation time














200.0 68.4 ± 7.5 9.7 ± 4.5 -3.7 ± 4.5 0.9 ± 4.6 -3.4 ± 4.6
400.0 58.5 ± 9.4 8.0 ± 7.6 -6.6 ± 5.4 0.1 ± 4.2 -2.9 ± 4.2
600.0 55.6 ± 8.7 7.2 ± 6.9 -7.6 ± 4.9 1.1 ± 4.2 -4.3 ± 4.2
800.0 53.6 ± 8.3 6.8 ± 6.4 -8.2 ± 4.5 0.4 ± 3.8 -4.8 ± 3.8
1,000.0 51.8 ± 8.1 8.0 ± 6.2 -8.0 ± 4.4 2.5 ± 3.6 -4.4 ± 3.6
Summed hysteresis for TI (DGhysteresis), averaged main cycle closure
(DGcycle), and relative affinity difference between wild type and mutant
CYP2D6 (DDGaffinity), calculated from the ensemble averages after a given
simulation time length per k point (ps/LP)
Eur Biophys J (2012) 41:1065–1076 1071
123
ease of comparison (k ! 1  k; oH=ok ! oH=ok). Data
obtained after 200, 600, and 1,000 ps per k point are shown
in this figure. The free energy profile of the reverse simu-
lation converges slowly towards the profile of the forward
simulation, and the HRE profile resembles the average of
the two TIs as the simulation time progresses. Note that
this was not the case for all simulations, as is also visible
from the integrated free energy differences of Table 1, and
that HRE energy profiles at high k values often yielded
higher ensemble averages than either of the TI (data not
shown).
Geometric analysis of states
To rationalize our simulation results, we collected the
trajectory data for physically meaningful states (WT,
WT ? R-PPD, WT ? S-PPD, Mut, Mut ? R-PPD, Mut ?
S-PPD, R-PPD, S-PPD) from all TI and HRE simulations
used to build the thermodynamic schemes. The trajectories
belonging to the same physical state were compared to find
the molecular reasons for hysteresis and for deviations
from cycle closure. All trajectories belonging to the same
state were subsequently pooled to obtain an ensemble
average. The atom-positional-root-mean-square deviations
(RMSD) of the protein backbone atoms never exceeded
0.25 nm within a given state, and the occurrence of the
secondary structure elements (Kabsch and Sander 1983)
and the total number of hydrogen bonds also remained very
similar (data not shown). We compared snapshots from our
simulation with the original crystal structure (pdb-code:
2F9Q) and with the newly released crystal structures
(3QM4, 3TBG, 3TDA). The backbone RMSD values are
maximally 0.16 nm, suggesting generally good structural
agreement. This analysis suggests that CYP2D6 remains
relatively stable during our simulations, with no significant
change or drift throughout the various simulation
processes.
Figure 6 shows some of the properties in the CYP2D6
active site that were monitored explicitly over the
simulations.
The improper dihedral (torsion) of the chiral carbon of
PPD, and the v1 angle of the F483 side chain were moni-
tored, because they are closely related to the thermody-
namic processes simulated. The PPD chiral improper
dihedral fluctuated by *15 around an average value of
?35 (R-PPD), -35 (S-PPD), or 180 (F-PPD) depending
on the simulation. The F483 side chain torsion was evenly
distributed in the mutant states (where it consisted of non-
interacting dummy atoms) and had a wide distribution
between 50 and 200 in the wild type states, with a highly
significant peak at 70 and a smaller one at approximately
150. Note that the F483 sidechain was observed in sig-
nificantly different orientations in the different crystal
structures, which seems to be adequately represented by
our simulations. Other properties, for example the distance
between the F483 and PPD rings, the distance between
the PPD ring and the heme iron, the PPD head torsion,
and head–tail polar group distance were more varied





200.0 20.0 ± 2.2 4.1 ± 3.8 13.0 ± 2.3
400.0 17.6 ± 2.4 2.1 ± 3.6 10.6 ± 3.6
600.0 18.7 ± 2.3 1.7 ± 3.4 9.3 ± 2.5
800.0 19.3 ± 2.3 0.4 ± 3.3 9.0 ± 3.2
1,000.0 19.7 ± 2.4 -0.7 ± 3.2 8.9 ± 2.9
Integrated free energy of the CYP2D6 mutation process from forward
and reverse thermodynamic integration, and Hamiltonian replica
exchange, after a given simulation time length per k point. In a
hysteresis-free system forward and reverse processes should yield free
energies of equal values with opposing signs
Fig. 5 Time evolution of free
energy profiles. Free energy
profiles for forward (black




(red solid lines) simulations of
the mutation process in absence
of PPD (Mut). The thickness of
the curves represents simulation
length (thin 200, intermediate
600, thick 1,000 ps/k point)
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throughout the simulations. In several cases one or two
trajectories from a particular state resulted in completely
different distributions in the visited conformations, but no
obvious pattern emerged which could be identified as a key
factor in the hysteresis. Replica exchange simulations
usually have a wider distribution and a better agreement
between trajectories from different processes compared
with the TI simulations, but not in every case. When the TI
(forward and reverse) and HRE trajectories of the same end
state were compared, we observed three typical cases:
1. all three simulations visit a highly overlapping con-
formational distribution (77 %);
2. TI simulations had different distributions, and HRE
overlapped with both (18 %); and
3. one of the three simulations had a significantly
different distribution (low overlap; 5 %)
The percentages indicate how much of the geometric
measurements fall in the respective categories. In more
than 75 % of cases 2 and 3 replica exchange simulations
visit regions in the conformational space that overlap with
the distributions obtained from TI simulations. Figure 7
displays two typical examples of geometric distributions,
when a difference between the three simulations occurs.
Even if not all simulations cover the same conforma-
tional space, the pooled trajectories may reveal differences
between the individual states concerning the PPD position
and backbone conformations. As a general trend PPD
seems to be further away from the heme iron in the wild
type enzyme with an average 0.58 nm distance, compared
with 0.46 nm in the mutant. It is likely that the disap-
pearance of the F483 ring gives the PPD more space to
move. Approximately 5 % of the time the C4 atom of PPD
gets within 0.25 nm of the heme Fe, whereas this not
observed for the wild type protein. Finally we monitored
the distribution of the angle between the norms of the PPD
ring system compared with the plane of the heme (Fig. 8).
The average angle of R-PPD in the wild type protein is
approximately 315 whereas it is 275 for S-PPD. On
mutation the distribution widens significantly and maxima
are shifted by approximately 25 in both cases. The wider
distribution again suggests more mobility in the mutant,
which may also correlate with the observation that the
calculated relative binding free energy of R-PPD and
S-PPD in the mutant is close to zero, because a larger
active site imposes fewer chiral restraints. The geometric
differences may also lead to a possible change in the
metabolic reaction rate for formation of the 4-hydroxy-
propranolol metabolite (Yoshimoto et al. 1995).
Rationalization of affinity differences
After checking the general structure, we will rationalize the
results obtained from the thermodynamic calculations.
Although the total number of hydrogen bonds associated
with propranolol remains the same (three hydrogen bonds
on average), the partners of PPD change substantially in the
different states (Table 5). R-PPD forms, on average, 0.5
hydrogen bonds with the protein whereas S-PPD forms
approximately 1.5. This difference is compensated by the
Fig. 6 CYP2D6 active centre. The full cytochrome P450 (WT)
structure is displayed on the left hand side, and a magnified view of
the active centre is shown on the right hand side. Propranolol
(R-PPD) is in black, heme in purple, and amino acids with significant
interactions are shown in colours according their position in the
sequence. Dashed lines in grey represent the distances measured in
the geometric analysis (PHE483-PPD, PPD-GLU216, and heme-
PPD). The PPD head–tail polar group distance, the chiral dihedral,
and the head torsion are shown in orange, red, and green respectively,
and the F483 ring torsion is shown in yellow
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hydrogen bonds formed between PPD and the water mol-
ecules in the cavity, suggesting that R-PPD interacts via
water bridges whereas S-PPD has more direct contact. The
main hydrogen bond acceptor in all cases was glutamate
216, which is commonly indicated to be one of the key
participants in ligand binding (Paine 2002; Rowland et al.
2006; de Graaf et al. 2007b; Unwalla et al. 2010). E216
interacts with R-PPD mostly through the positively charged
NH2 group in the tail region, but the hydrogen bond is only
present in 30 % of the simulation time. On the other hand
S-PPD forms a very stable H-bond with the NH2 group, and
a weaker hydrogen bond with its OH group, resulting in an
average of 1.2 hydrogen bonds between the two species.
Another noteworthy difference in the H-bonding of R and
S-PPD is the number of hydrogen bond partners during the
simulations (Table 5). The F483A mutation increases
the number of partners (another hint of mobility), and the
observed number of hydrogen-bond partners is larger for
S-PPD than for R-PPD. An increase in possible hydrogen-
bonding partners suggests more conformational freedom
within the binding pocket, leading to a larger entropic
contribution to the free energies. Despite the increase in the
number of hydrogen-bonding partners, no additional stable
hydrogen bonds were observed between the protein and
propranolol.
The conformational entropy of different states was
estimated by use of the Schlitter (1993) formula for PPD
and the F483 side chain. For PPD, the configurational
entropy was determined by performing a translational fit
for all heavy atoms before the analysis. The rotational and
translational entropy was included in a second analysis,
where the fit was performed on the protein backbone
atoms, as was the case for the F483 side chain. Table 6 lists
Fig. 7 Sampling examples. Examples of distributions obtained in
HRE and TI simulations in selected cases. Distributions for the same
state shown for forward TI (dashed blue), reverse TI (green dotted),
and replica exchange (red solid). a the F483–PPD ring distance in the
WT ? R-PPD state, where replica exchange did not sample the
reverse TI conformations. b The PPD head torsion in the Mut_R state,
where replica exchange overlaps with both (mutually distinct) TI
distributions equally well
Fig. 8 Propranolol orientation. Distribution of the angle between the
norms of the PPD and heme ring systems. Different colours represent
the distribution of orientation in the different states defined in Fig. 4









PPD N–H ? E216 0.31 0.90 0.31 0.78
PPD OH ? E216 0.10 0.39 0.0 0.29
PPD-prot 0.47 1.42 0.62 1.46
PPD-solv 2.58 1.60 2.38 1.69
PPD total 3.05 3.02 3.00 3.15
Partners 34 53 71 84
The number of hydrogen bonds between propranolol and CYP2D6
(E216 and total (PPD-prot)), propranolol and water molecules (PPD-
solv), and in total (PPD total) averaged over the simulation of states
described in Fig. 4. Number of hydrogen bond donor–acceptor pairs
between the protein and propranolol (partners)
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the conformational entropy in each state, for the F483 side
chain and for PPD. In this table we also calculate the
entropy change upon transfer of a specific PPD stereo
isomer between CYP mutants, and the exchange of dif-
ferent PPDs within a given protein. The last row contains
the calculated contribution to the relative free energy dif-
ference in PPD affinity (DDGaffinity). The entropy calcula-
tions were performed on an equal number of snapshots
from the combined trajectory of each state. Even the
combined trajectories were not long enough for the system
to converge in all the cases, but as the entropy increase as a
function of time is very similar, the differences in con-
formational entropy are converging faster than the indi-
vidual entropies themselves. The conformational entropy
of the F483 side chain is somewhat larger in the WT ?
R-PPD state than in the WT ? S-PPD state, whereas it is
identical in both mutant states (where it is not interacting,
and therefore free to rotate), leading to a -4.8 kJ/mol
contribution to DDGaffinity toward S-PPD upon mutation
The internal conformational freedom of PPD does not
change much upon mutation (?0.9 kJ/mol), but when
rotational and translational contributions are also consid-
ered, mutating the enzyme yields -2.6 kJ/mol entropic
preference towards S-PPD again. The total -7.4 kJ/mol
entropic contributions corresponds to the experimental and
calculated free energy difference, suggesting that the
driving force of stereoselectivity may be entropic rather
than enthalpic in this particular case. This seems to agree
with observations that a very similar number of hydrogen
bonds were observed (Table 5). Although the starting
structure of the simulations might affect the observed
ensemble (and thus enthalpic and entropic contributions),
the closing thermodynamic cycles, the generally good
agreement between the structure backbones, and the fact
that the F483 side chain samples conformations very sim-
ilar to those observed in the different crystal structures
increases confidence in our results.
Conclusions
A set of thermodynamic integration (TI), and Hamiltonian
replica exchange TI simulations were performed on wild
type and F483A mutant versions of cytochrome P450 2D6
with R and S-propranolol, in an attempt to improve our
previously poorly converged study (de Graaf et al. 2007a).
The simulations were performed with a slightly improved
version of the original force field (45A4), and were started
from a simulation snapshot based on the crystal structure of
CYP2D6 rather than a homology model. In addition, the
simulation time was more than five times longer. Conver-
gence was monitored in terms of the deviation from cycle
closure and hysteresis. Prolonged TI simulations have shown
increased internal consistency and a significant reduction—
but not elimination—of hysteresis and deviations of cycle
closure, and the calculated free energy differences scatter
substantially compared with the experimentally derived
values. Utilizing Hamiltonian replica exchange resolved the
thermodynamic discrepancies even after 200 ps per k point
of simulation, and further prolonged simulation times led
to reduced statistical uncertainty and more converged
thermodynamic results in agreement with experiments.
Geometric analysis of the trajectories collected for each state
revealed that at least 600 ps per k point of simulation was
needed to reduce fluctuations, and that the replica exchange
simulations could significantly reduce discrepancies in
the sampled distributions. Altogether, Hamiltonian replica
exchange proved to be a useful tool to ensure internal con-
sistency of the thermodynamic data. However, the geometric
analysis proved that complex systems such as CYP2D6
and propranolol might require even longer simulation time
in addition to improved sampling techniques to provide
proper conformational distributions. The rationalization
based on pooled simulation data did not reveal significant
differences in enthalpic contributions to the free energy
differences, but a changed mobility of the ligand molecule
suggests mostly entropic contributions to differences
between binding affinities.
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PPD tr ? rot
(kJ/mol)
-T 9 SWT?R-PPD -75.6 -121.9 -178.2
-T 9 SMut?R-PPD -91.1 -119.4 -182.1
-T 9 SWT?S-PPD -70.9 -133.2 -181.3
-T 9 SMut?S-PPD -91.2 -129.8 -187.7
-T 9 DSmut
R -15.5 2.5 -3.8
-T 9 DSmut
S -20.3 3.4 -6.4
-T 9 DSbind
wt 4.7 -11.3 -3.0
-T 9 DSbind
M -0.1 -10.4 -5.6
-T 9 DDSaffinity -4.8 0.9 -2.6
Contribution of the conformational entropy to the free energy in a
given state was calculated for the F483 side chain (F483 ring), pro-
pranolol (PPD), and for propranolol including translational and
rotational motion relative to the protein (PPD tr ? rot). From the
individual contributions in each state, the contributions of R-PPD or
S-PPD binding (-T 9 DSbind), and of the mutation process with the
respective PPDs bound (-T 9 DSmut) can be calculated. Finally the
free energy contribution of conformational entropies to the relative
difference in affinities (-T 9 DDSaffinity) is calculated
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